Navigation Links
Vitrasert Sterile Intraviteral Implant

ProductsVitrasert Sterile Intraviteral Implant
Company Bausch & Lomb Storz
Item Vitrasert Sterile Intraviteral Implant
Features The Vitrasert implant contains ganciclovir embedded in a polymer-based system that slowly releases the drug. The implant, surgically placed in the posterior segment of the eye, allows diffusion of the drug locally to the site of infection over an extended period of months. Implantation normally takes less than one hour, requires only local anesthesia, and is conducted in an outpatient, day-surgery setting. Immediately following insertion of the implant, most patients experience transient blurred vision in the operated eye, which generally clears within two to four weeks. The implant can be removed when depleted of drugs, usually within five to eight months, and a new Vitrasert implant can be inserted.
Description Vitrasert implant is a device that delivers ganciclovir intraocularly in patients with Aids-related Cytomegalovirus (CMV) Retinitis. This approach can significantly delay progression of CMV when compared with conventional intravenous treatment. The Vitrasert implant contains ganciclovir embedded in a polymer-based system that slowly releases the drug. The implant, surgically placed in the posterior segment of the eye, allows diffusion of the drug locally to the site of infection over an extended period of months.
Info Bausch & Lomb Storz
Customer Service: (585) 338-6000

Related medicine products :

1. Sterile Blades
2. Sterile Cordless Eraser Tips
3. Sensitive Eyes Sterile Saline Spray
4. Sterile Preserved Saline Solution
5. Lens Plus Sterile Saline Solution
6. Sterile Preserved Daily Cleaner
7. Non-Sterile Oncoseed (Iodine-125 Seeds)
8. Oncoseed Sterile Convenience Pack (Iodine-125 Seeds)
9. Balanced Salt Solution (Sterile Irrigating Solution)
10. Hoffmann Classic Sterile Wrist Kit
11. Biotrace Sterile Barium Sulfate USP
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTip is a unipolar tined permanent pacing lead. Due to advanced technology, VascoTip 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm), 5 mm, 6 mm....
VascoTwist is a low profile unipolar permanent pacing lead with a retractable screw. Due to advanced technology VascoTwist 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
Medicine Products:
(Date:12/9/2016)... ... December 09, 2016 , ... The Justin Veatch ... Inc. (NCADD) is recommending the film Whispering Spirits and its discussion ... of Columbia as an education tool in the war against teen drug abuse. ...
(Date:12/9/2016)... NJ (PRWEB) , ... December 09, 2016 , ... ... Founders Ball at The Pierre Hotel in New York, NY, on December 3rd, ... benefactors, dignitaries and physicians attended the annual event, which raised over $1 million ...
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical ... 2017. The name change aligns the entire company with its existing Quality ... quality. , “We are very proud of the achievements associated with the West ...
(Date:12/8/2016)... ... 08, 2016 , ... ZyDoc , a New York-based ... Data Capture Methods for Input to Electronic Health Records: A Comparative Usability Study” ... comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s MediSapien™ ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand ... “What’s In Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety ... dental implant and prosthetic market in the U.S. is projected to reach $6.4 billion ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016   TriNetX ... Nationwide Children,s Hospital signed a membership ... accelerate the development of new cures. ... representing over 57 million patients globally, biopharmaceutical companies ... together to improve protocol design, site selection, patient ...
(Date:12/8/2016)... HARRISBURG, Pa. , Dec. 8, 2016 /PRNewswire-USNewswire/ ... and Secretary of Drug and Alcohol Programs ... anxiety and insomnia medications, known as benzodiazepines, developed ... "Benzodiazepines are medications that are frequently ... "However, when they are used with opioid pain ...
(Date:12/8/2016)... 2016  A new study by a pair of ... opioid therapy to treat chronic pain is not only ... harmful consequences, including death. Palliative care physicians ... Mehta , M.D., authored the study which provides a ... The study was published in the December 2016 edition ...
Breaking Medicine Technology: